Navigation Links
Nutrastar Announces First Quarter 2013 Results, Maintains Full Year Revenue Guidance Range of $44 million to $46 Million

HARBIN, China, May 14, 2013 /PRNewswire-FirstCall/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its financial results for the quarter ended March 31, 2013.

Financial Highlights

  • Net revenue increased 8.0% to $7.41 million, as compared to $6.86 million in the quarter ended March 31, 2012.
  • Gross profit increased 11.0% to $5.64 million, up from $5.08 million in the comparable 2012 quarter, representing a gross margin of 76.1%.
  • Net income was $3.41 million, as compared to $2.95 million in Q1 2012.
  • Basic and diluted EPS were $0.21 and $0.20, respectively, with 15.86 million basic shares and 16.99 million diluted shares outstanding.
  • Management Commentary

    "Nutrastar's first quarter 2013 was marked by continued sales growth, increased profitability and a growing balance sheet. Commercially cultivated Cordyceps, our core consumer product business, saw a year-over-year sales increase of 11.4%. Our functional health beverages and organic specialty products businesses experienced a sales decrease of 7.9% and 1.1% in the quarter, respectively, due to the timing of the reorder cycle from the beverage distributors. As a percentage of revenue, gross profit increased by 2% year-over-year, reaching 76.1%. As expected, we saw a slight improvement in our cost of goods sold on a percentage basis resulting from our increased production capacity and utilization. Our cash balance at the end of the quarter remained at a strong $77.9 million or approximately $4.59 per diluted share, as seen and verified at the bank by our independent auditor," stated, Ms. Lianyun Han, CEO of Nutrastar.

    Ms. Han continued, "Looking into Q2 and the remainder of 2013, we are confident in our ability to maintain our upward momentum and capitalize on rising demand stemming from China's young, increasing affluent and aging populations. Strategic advertising and marketing initiatives will remain steadfast and continue to be aimed at these consumer populations and others. We will continue to seek out and identify new and attractive markets within China for our premium consumer products as well as consider complementary acquisitions that are accretive to the company and our shareholders."

    Outlook for the Year Ending December 31, 2013

    Based on management's current expectations, the Company maintains its expectation that 2013 revenue will be in the range of $44 million to $46 million, representing an approximate 19% to 25% top line increase year-over-year.

    Request for Call with Management

    Investors are invited to request a call with Nutrastar's management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.

    For more information regarding Nutrastar's financial performance during the quarter ended March 31, 2013, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission on or about May 14, 2013. Management is available to discuss the financial results with investors should they have any questions. To arrange a call with the management team, please contact Investor Relations at 305-918-7000.

    About Nutrastar International Inc.Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 330 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at or e-mail:

    Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at:

    Safe Harbor StatementThis news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies.  All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts.  These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions.  These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors.  You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

    For more information, please contact:

    Howard Gostfrand
    American Capital Ventures
    Tel:  +1-305-918-7000


    For the Three Months EndedMarch 31,20132012REVENUE$7,411,136$6,861,018Cost of goods sold (1,772,288)(1,778,568)GROSS PROFIT 5,638,8485,082,450Selling expenses (430,463)(382,358)General and administrative expenses (592,515)(664,705)Income from operations 4,615,8704,035,387Other income (expenses): Interest income 83,74167,218Foreign exchange differences (5,187)2,404Change in fair value of warrants -(4,029)Total other income (expenses) 78,55465,593Income before income taxes 4,694,4244,100,980Provision for income taxes (1,279,740)(1,151,402)NET INCOME3,414,6842,949,578OTHER COMPREHENSIVE INCOME: Foreign currency translation adjustments 239,74779,753COMPREHENSIVE INCOME$3,654,431$3 ,029,331Earnings per share Basic






    0.18Weighted average number of shares outstanding Basic 15,863,82615,361,458Diluted 16,995,92816,512,858See accompanying notes to consolidated financial statements NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(AMOUNTS EXPRESSED IN US DOLLARS) March 31,December 31,20132012(Unaudited)ASSETSCURRENT ASSETS  Cash and cash equivalents



    75,526,533 Accounts receivable 82,29981,497 Inventories 1,723,342965,251 Prepayments and other receivables 879,3101,321,726Total current assets 80,627,06477,895,007OTHER ASSETS  Intangible assets, net 1,436,4331,552,022 Property, plant and equipment, net 15,789,12715,991,060Total assets$97,852,624$95,438,089LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIES  Other payables and accruals



    1,481,198 Taxes payable 1,534,3662,981,136 Due to a related party 158,200150,036 Preferred stock dividend payable 583,920528,528 Warrants liabilities 173173Total current liabilities 3,902,5615,141,071Total liabilities 3,902,5615,141,071COMMITMENTS AND CONTINGENCIES (Note 17) STOCKHOLDERS' EQUITY  Preferred Stock, $0.001 par value, 1,000,000 shares authorized, 113,010
     shares issued and outstanding; aggregate liquidation preference amount:
     $3,164,280 and $3,164,280, plus accrued but unpaid dividend of $583,920
     and $528,528, at March 31, 2013 and December 31, 2012, respectively 2,577,3242,577,324Common stock, $0.001 par value, 190,000,000 shares authorized,
    5,907,381 shares issued and 15,863,826 shares outstanding at
    March 31, 2013 and December 31, 201215,90815,908 Additional paid-in capital 19,083,59219,029,586 Statutory reserves 5,327,2414,960,023 Treasury stock, at cost, 43,555 shares
     as of March 31, 2013 and December 31, 2012(78,767)(78,767) Retained earnings 61,318,00658,325,932 Accumulated other comprehensive income 5,706,7595,467,012Total stockholders' equity 93,950,06390,297,018Total liabilities and stockholders' equity$97,852,624$95,438,089See accompanying notes to consolidated financial statements NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)(AMOUNTS EXPRESSED IN US DOLLARS) For the Three Months EndedMarch 31,20132012CASH FLOWS FROM OPERATING ACTIVITIES: Net income



    2,949,578Adjustments to reconcile net income to cash provided by operating activities: Change in fair value of warrants -4,029Depreciation and amortization 362,996309,252Loss on disposal of property and equipment Share-based compensation expense 54,006101,483(Increase) decrease in assets: Accounts receivable (584)(7,911)Inventories (754,380)(430,950)Prepayments and other receivables 445,232516,790Increase (decrease) in liabilities: Accounts payable -(6,332)Other payables and accruals 83,74948,578Taxes payable (1,452,440)(1,092,388)Net cash provided by operating activities 2,153,2632,392,129CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property, plant and equipment -(15,927)Net cash used in investing activities -(15,927)CASH FLOWS FROM FINANCING ACTIVITIES: Decrease in restricted cash -4,170Net cash (used in) provided by financing activities -4,170Foreign currency translation adjustment 262,31759,349INCREASE IN CASH AND CASH EQUIVALENTS2,415,5802,439,721CASH AND CASH EQUIVALENTS, at the beginning of the period 75,526,53354,556,329CASH AND CASH EQUIVALENTS, at the end of the period$77,942,113$56, 996,050NON-CASH TRANSACTIONS Preferred stock and dividend converted into common stock



    978,282Preferred stock dividend payable 55,39265,144Share-based payment to officers and directors under equity incentive plan 54,006101,483SUPPLEMENTAL DISCLOSURE INFORMATION Income taxes paid



    1,899,301See accompanying notes to consolidated financial statements 

    SOURCE Nutrastar International Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Nutrastar Announces Full Year 2012 Results, Issues 2013 Revenue Guidance
    2. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
    3. Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events
    4. Pro-Dex, Inc. Announces Fiscal Third Quarter And Nine-Month Results
    5. Arbor Pharmaceuticals Announces FDA Approval of First NDA
    6. Comprehensive Care Corporation Announces Pharmacy Savings Management Agreement With Utica City School District
    7. Alere Inc. Announces Tender Offer and Consent Solicitation for Any and All of its 9.00% Senior Subordinated Notes due 2016
    8. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
    9. Telik Announces First Quarter 2013 Financial Results
    10. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.
    11. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
    Post Your Comments:
    (Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
    (Date:10/4/2017)... Centers for Disease Control and Prevention (CDC), influenza vaccination should take ... communities across Massachusetts , Connecticut , ... through the end of the month. *Some exclusions apply ... ... by the end of October, according to the Centers for Disease Control ...
    (Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
    Breaking Medicine Technology:
    (Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
    (Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
    (Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
    (Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
    (Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
    Breaking Medicine News(10 mins):